首页> 外文期刊>Neuroscience: An International Journal under the Editorial Direction of IBRO >THE EFFECTS OF GINSENOSIDE Rg1 ON CHRONIC STRESS INDUCED DEPRESSION-LIKE BEHAVIORS, BDNF EXPRESSION AND THE PHOSPHORYLATION OF PKA AND CREB IN RATS
【24h】

THE EFFECTS OF GINSENOSIDE Rg1 ON CHRONIC STRESS INDUCED DEPRESSION-LIKE BEHAVIORS, BDNF EXPRESSION AND THE PHOSPHORYLATION OF PKA AND CREB IN RATS

机译:人参皂甙Rg1对慢性应激诱导的大鼠抑郁样行为,BDNF表达以及PKA和CREB磷酸化的影响

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Depression is a common neuropsychiatric disorder which has been associated with a wide range of structural and functional changes within specific brain regions. Ginsenoside Rg1 has been shown to exert a number of neuroprotective effects as demonstrated in various in vivo and in vitro studies. However, little information is available regarding the site and mechanisms of ginsenoside Rg1 in promoting antidepressant effects. The present study aimed to investigate the neuroprotective and ameliorating effects of ginsenoside Rg1 on depression-like behavior as induced by chronic unpredictable mild stress (CUMS). The results showed that CUMS was effective in producing depression-like behaviors in rats as indicated by decreased responses in sucrose preference and forced swim tests which were associated with ultrastructural changes in neurons within the amygdala. Moreover, levels of PKA and CREB phosphorylation and the expression of brain-derived neurotrophic factor (BDNF) were decreased in the amygdala of CUMS rats. Remarkably, chronic ginsenoside Rg1 (40 mg/kg, i.p., 5 weeks) treatment significantly ameliorated these behavioral and biochemical alterations associated with CUMS-induced depression. Taken together, the results of the present study demonstrate that ginsenoside Rg1 exhibits antidepressant-like effects against CUMS-induced depression. This amelioration of depression-like behaviors by ginsenoside Rg1 appears to be mediated, at least in part, by a CREB-regulated increase of BDNF expression in the amygdala of rats. Therefore, these findings reveal the therapeutic potential of ginsenoside Rg1 for use in clinical trials in the treatment of depression. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.
机译:抑郁症是一种常见的神经精神疾病,与特定大脑区域内广泛的结构和功能变化有关。人参皂苷Rg1已显示出多种神经保护作用,如各种体内和体外研究所证明的。但是,关于人参皂苷Rg1促进抗抑郁作用的部位和机制的信息很少。本研究旨在研究人参皂苷Rg1对慢性不可预测的轻度应激(CUMS)诱导的抑郁样行为的神经保护和改善作用。结果表明,CUMS可有效地在大鼠中产生抑郁样行为,其表现为蔗糖偏爱反应的降低和强迫游泳试验,这与杏仁核内神经元的超微结构改变有关。此外,在CUMS大鼠的杏仁核中,PKA和CREB的磷酸化水平以及脑源性神经营养因子(BDNF)的表达降低。值得注意的是,慢性人参皂甙Rg1(40 mg / kg,腹腔注射,连续5周)治疗可显着改善与CUMS诱发的抑郁症相关的行为和生化改变。两者合计,本研究的结果表明,人参皂苷Rg1对CUMS诱导的抑郁症表现出抗抑郁样作用。人参皂苷Rg1对抑郁样行为的改善似乎至少部分是由CREB调节的大鼠杏仁核中BDNF表达的增加所介导的。因此,这些发现揭示了人参皂苷Rg1在抑郁症临床试验中的治疗潜力。 (C)2016年IBRO。由Elsevier Ltd.出版。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号